Leaflet DOBUTAMINA ADMEDA 250mg solution for infusion

Product code:
W55405001
Quantity:
1
Indicated for:
cardiogenic shock; acute heart failure
Route of administration:
infusion
Substance:
dobutamine (vasopressor)
ATC
C01CA07 — Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Adrenergic and dopaminergic agents
Dobutamine is a medication used for the treatment of acute heart failure and other conditions requiring increased cardiac contractility. It is a beta-adrenergic agonist that stimulates the heart to pump blood more efficiently.

The medication is administered intravenously, usually in a hospital setting, under medical supervision. It is effective in improving cardiac function and stabilizing patients with severe heart failure.

Side effects may include tachycardia, high blood pressure, nausea, and, in rare cases, arrhythmias. Close monitoring of cardiac function is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Dobutamine. This medication must be administered exclusively in controlled environments, such as hospitals.

General data about DOBUTAMINA ADMEDA 250mg

Substance:
dobutamine
Date of latest medicines list:
01-06-2026
Product code:
W55405001
Concentration:
250mg
Pharmaceutical form:
solution for infusion
Quantity:
1
Product type:
Generic medicine
Price:
31.02 RON
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
HAUPT PHARMA WULFING GMBH - GERMANIA
Holder:
ADMEDA ARZNEIMITTEL GMBH - GERMANIA
Number:
2466/2010/01
Shelf life:
3 years

Pharmaceutical forms available for dobutamine

Concentrations available for dobutamine

  • 12.5mg/ml
  • 125mg/ml
  • 250mg
  • 250mg/20ml
  • 250mg/50ml
  • 5mg/ml